美国联合医疗宣布Lungfx™设备获FDA批准用于集中式离体肺灌注

美股速递
Jun 29

美国联合医疗公司宣布,其Lungfx™设备已获得美国食品药品监督管理局的批准,可用于集中式的离体肺灌注操作。这一监管里程碑标志着公司在器官护理技术领域取得了重要进展,有望提升供体肺的评估、修复和利用效率,从而为更多等待肺移植的患者带来希望。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10